⌘K

Home/Filings/4/0001171843-19-000755

4//SEC Filing

Ahn Edward S. 4

Accession 0001171843-19-000755

CIK 0000898437other

View on SEC.gov Company Profile

Filed

Feb 5, 7:00 PM ET

Accepted

Feb 6, 9:15 AM ET

Size

4.9 KB

Accession

0001171843-19-000755

Insider Transaction Report

Form 4

Period: 2019-02-04

Anika Therapeutics, Inc.ANIK

Chief Tech. & Strategy Officer

Transactions

Tax Payment
Common Stock
2019-02-04$38.10/sh−685$26,099→ 6,575 total

Footnotes (1)

[F1]Reflects an aggregate of 685 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to restricted shares that vested in full on February 4, 2019.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Anika Therapeutics, Inc.

CIK 0000898437

Entity typeother

Related Parties

1

filerCIK 0001623597

Filing Metadata

Form type: 4
Filed: Feb 5, 7:00 PM ET
Accepted: Feb 6, 9:15 AM ET
Size: 4.9 KB

View on SEC.gov